Verian Potential Name For Baxter Protein-Free Antihemophilic Factor VIII
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Verian is a potential name for Baxter’s protein-free factor VIII product that is pending at FDA. The firm submitted the name to the Patent & Trademark Office for antihemophilic factor used for the treatment of hemophilia.